ANACE SAID: Open Payments
NPI 1487696910 · WALLINGFORD, CT. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$3,367 in 168 payments from 26 companies in 2025. Trend: 2023 $3,725 · 2024 $4,332 · 2025 $3,367
Food & beverage: $3,367
| Company | Payments | Amount |
|---|---|---|
| Indivior Inc. | 24 | $423 |
| ViiV Healthcare Company | 12 | $347 |
| ABBVIE INC. | 30 | $324 |
| Axsome Therapeutics, Inc. | 18 | $264 |
| AstraZeneca Pharmaceuticals LP | 9 | $193 |
| Lilly USA, LLC | 8 | $190 |
| Orexo US, Inc. | 9 | $170 |
| Gilead Sciences, Inc. | 8 | $163 |
| Janssen Pharmaceuticals, Inc | 6 | $155 |
| Braeburn Inc. | 8 | $154 |
Products named: SUBLOCADE, APRETUDE, Sunosi, Zubsolv, MOUNJARO, BREZTRI, UBRELVY, SPRAVATO.
Industry payments across CT — which companies pay providers there.
